France IVD Market is expected to be more than US$ 5 Billion by the end of the year 2024

Share on facebook
Share on twitter
Share on linkedin
As per Renub Research report France In Vitro Diagnostics market is expected to be around US$ 5 Billion by the end of the year 2024.

According to Renub Research market research report “France In-Vitro Diagnostics (IVD) Market by Segments, Types (Laboratory Reagents, Instruments), & Companies” the France In Vitro Diagnostics Market is expected to be more than US$ 5 Billion by the end of the year 2024. IVDs are considered as the “silent champion” of healthcare, and these devices are extremely valuable as they can spot disease in early-stage and risk factors, which are helpful in early intervention and prevention. IVDs are used to examine the biological samples such as tissues, stool, urine, blood, and other body fluids with the help of different medical instruments and laboratory reagents. In vitro diagnostic tests are performed at hospitals, point-of-care centers, and stand-alone laboratories.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=france-in-vitro-diagnostics-market-p.php

Europe is the second-largest market for IVD after North America, and France is having a much larger market share among other European countries. IVD market in France is growing due to the rise in infectious and chronic disease. Advancement in technology like digital pathology solutions, minimally invasive techniques, and self-care tests such as pregnancy test and glucose test are also boosting the In vitro diagnostic market in France. Aging population of France is also a growth factor; almost 20% of France population is 65+ years.

Due to increased incidences of infectious diseases such as tuberculosis, HIV, AIDS, malaria, rabies, ebola virus, and pertussis, the IVD market in France is in its development stage. As infectious disease increases, demand for the IVD market is increasing, for example, spreading 357 generic infectious diseases, of which France contributes 225.

Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=france-in-vitro-diagnostics-market-p.php

Immunochemistry dominates the France IVD Market

France In-Vitro Diagnostics (IVD) Market is segmented into immunochemistry, hematology, infectious immunology, microbiology, biochemistry, and genetic testing. Immunochemistry has the highest market in the France IVD segment.

Market Summary:

• By Segments: Immunochemistry holds the largest market share than other segments in this research report. Market and market share of hematology, immunochemistry, genetic testing, microbiology, infectious immunology, and biochemistry are given in this report.

• By Types: On the basis of product types, Laboratory Reagents are having more market share than medical instruments. Market and market share of Laboratory Reagents and Instruments are provided in France IVD Market research report.

• By Companies: Overview, Initiatives & Recent Developments and Sales Analysis of Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific and Sysmex Corporation is given in this report.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: www.renub.com